The investigators explained that GLP-1 receptor agonists appear to be able to help resolve MASH without worsening fibrosis. Those findings have been confirmed in mouse models and in multiple studies ...

Recently presented preclinical data show that EA Pharma Co. Ltd.'s EA-3571 is a highly potent dual inhibitor of enteropeptidase and trypsin with luminal action, resulting in potential anti-insulin ...

Metabolic dysfunction-associated steatohepatitis (MASH) significantly increases the risk of liver cirrhosis and hepatocellular carcinoma. While fibroblast growth factor 21 (FGF21) analogs have shown ...

Researchers from Toronto’s Sinai Health have published a study that sheds light on a central mystery for scientists studying ...

Researchers at Waseda University in Japan have identified a gene that, when rendered nonfunctional in mice, causes the rodents to develop telltale signs of the liver disease metabolic ...